Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis
You can see in this phase 1 study looking at a dual agonist a very encouraging early profile observed in healthy subjects with a BMI of greater than 30 kg/m 2 , Neutel said during the presentation
Fujisaka S, Watanabe Y, Tobe K
TL;DR: In a large sample of US Veterans, GLP-1 drugs were associated with reduced risk of substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimers disease and dementia), coagulation disorders, cardiometabolic disorders, infectious illnesses and several respiratory conditions, but increased risk of gastrointestinal issues, hypotension (low blood pressure), and some kidney-related conditions